Presentation at Drug Discovery Modality Study Group of JBA
- shinyoshida
- Jul 11
- 1 min read
Updated: Jul 14
We will be giving a pitch presentation at JBA (Japan Bioindustry Association) Drug Discovery Modality Study Group.
The theme of the 7th General Assembly is "Development of Drug Discovery through Innovation and Combination of Technologies".
Event Overview
Date and Time: Friday, July 18, 2025, 14:30–17:00*
*Our pitch presentation: 16:00-16:40
Venue: Hybrid of Online (Zoom) and Onsite (JBA Office)
Organizer: Japan Bioindustry Association (JBA), Drug Discovery Modality Study Group "Biomaterials Protective Hydrogels Support Drug Discovery Modality" We have developed zwitterionic hydrogel technology for long-term stabilization of biomaterials such as enzymes, nucleic acids, and proteins. This presentation will introduce the hydrogel technology that dramatically improves the storage stability, blood retention, and reaction efficiency of biopharmaceuticals with the successful examples.
